The Role of MRAs in the Management of HF
Description

Leaning Objective
Upon completion of this activity, you should be able to: 

  1. Incorporate GDMT, newer therapies, and interprofessional team strategies into treatment care plans for the management of HF to improve care coordination, communication, and patient outcomes. 

Faculty

Tara E. Schreck, PharmD, BCACP 

Riverside Methodist Hospital  

Columbus, Ohio 

Disclosures 

Nothing to Disclose 

 

Emma Siegel, PharmD, BCACP 

Riverside Methodist Hospital  

Columbus, Ohio 

Disclosures 

Nothing to Disclose 

 

Target Audience 
The primary target audience for this education are members of the HF Care Team, including physicians, advanced practice providers (APPs), PharmDs, and other HCPs.

 

Important Dates  
Date of Release: December 18, 2025
Term of Approval/Date of Expiration: December 15, 2026

Acknowledgement  
This activity is supported by an unrestricted educational grant from Bayer AG.
 

Summary
Availability:
On-Demand
Access expires on Dec 15, 2026
Cost:
FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By